Year: 2016
Type: review
Study design: Observational Study
Abstract: Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide association studies have transformed our understanding of MM predisposition, but individual studies have had limited power to discover risk loci. Here we perform a meta-analysis of these GWAS, add a new GWAS and perform replication analyses resulting in 9,866 cases and 239,188 controls. We confirm all nine known risk loci and discover eight new loci at 6p22.3 (rs34229995, P=1.31 × 10(-8)), 6q21 (rs9372120, P=9.09 × 10(-15)), 7q36.1 (rs7781265, P=9.71 × 10(-9)), 8q24.21 (rs1948915, P=4.20 × 10(-11)), 9p21.3 (rs2811710, P=1.72 × 10(-13)), 10p12.1 (rs2790457, P=1.77 × 10(-8)), 16q23.1 (rs7193541, P=5.00 × 10(-12)) and 20q13.13 (rs6066835, P=1.36 × 10(-13)), which localize in or near to JARID2, ATG5, SMARCD3, CCAT1, CDKN2A, WAC, RFWD3 and PREX1. These findings provide additional support for a polygenic model of MM and insight into the biological basis of tumour development.
Source: Nature Communications
DOI: 10.1038/ncomms12050
Authors: Jonathan S. Mitchell, Ni Li, Niels Weinhold, Asta Försti, Mina Ali, Mark van Duin, Gudmar Thorleifsson, David C. Johnson, Bowang Chen, Britt-Marie Halvarsson, Daniel F. Gudbjartsson, Rowan Kuiper, Owen W. Stephens, Uta Bertsch, Peter Broderick, Chiara Campo, Hermann Einsele, Walter A. Gregory, Urban Gullberg, Marc Henrion, Jens Hillengass, Per Hoffmann, Graham H. Jackson, Ellinor Johnsson, Magnus Jöud, Sigurður Y. Kristinsson, Stig Lenhoff, Oleg Lenive, Ulf-Henrik Mellqvist, Gabriele Migliorini, Hareth Nahi, Sven Nelander, Jolanta Nickel, Markus M. Nöthen, Thorunn Rafnar, Fiona M. Ross, Miguel Inacio da Silva Filho, Bhairavi Swaminathan, Hauke Thomsen, Ingemar Turesson, Annette Vangsted, Ulla Vogel, Anders Waage, Brian A. Walker, Anna-Karin Wihlborg, Annemiek Broyl, Faith E. Davies, Unnur Thorsteinsdottir, Christian Langer, Markus Hansson, Martin Kaiser, Pieter Sonneveld, Kari Stefansson, Gareth J. Morgan, Hartmut Goldschmidt, Kari Hemminki, Björn Nilsson, Richard S. Houlston
Institutions: Institute of Cancer Research, Heidelberg University, University of Arkansas for Medical Sciences, German Cancer Research Center, Lund University, Erasmus MC Cancer Institute, deCODE Genetics (Iceland), University of Iceland, National Center for Tumor Diseases, Universitätsklinikum Würzburg, University of Leeds, University of Bonn, University of Basel, Royal Victoria Infirmary, National University Hospital of Iceland, Skåne University Hospital, Sahlgrenska University Hospital, Karolinska Institutet, Uppsala University, Wessex Regional Genetics Laboratory, University of Southampton, Copenhagen University Hospital, Rigshospitalet, National Research Centre for the Working Environment, Norwegian University of Science and Technology, Universität Ulm, Broad Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $6,990
Funders: Multiple Myeloma Research Foundation, National Cancer Research Institute, Wellcome Trust, Cancer Research UK, University of Leeds, Rosetrees Trust, Deutsche Forschungsgemeinschaft, Stiftelsen för Strategisk Forskning, Lunds Universitet, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, Deutsches Zentrum für Neurodegenerative Erkrankungen, Deutsche Krebshilfe, Svenska Läkaresällskapet, Marcus och Amalia Wallenbergs minnesfond, Heinz Nixdorf Stiftung, National Institutes of Health, Medical Research Council, National Cancer Institute
Awards: G1342751976, G1621533078, G2238503249, G3041445225, G3605022155, Fokus på multipelt myelom, The Avon Longitudinal Study of Parents and Children: An international resource for population
genomics and lifecourse epidemiology. Core Programme Support 2011-2015 and Core programme support 2014-2019, Growth Control in Multiple Myeloma, G49395674, G5734460833, G7660237446, G80277943
OpenAlex ID: W2467557936
